Commentary

Video

NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula

Fact checked by:

Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with chemosis warrants suspicion for a cavernous carotid fistula, emphasizing careful examination for dilated conjunctival vessels and the need for imaging for accurate diagnosis and timely intervention.

This latest episode of the “NeuroOp Guru”—hosted by Andrew G. Lee, MD, from Houston Methodist, and joined by Drew Carey, MD, from Johns Hopkins University—features the importance of recognizing cranial nerve six (CN VI) palsy with chemosis as a potential sign of a cavernous carotid fistula (CCF). This condition, particularly the low-flow type, can be challenging to diagnose due to its rarity and overlapping features with more common conditions like thyroid eye disease.

The discussion centered on a population-based study1 from the Mayo Clinic using data from Olmsted County. The study identified only 10 cases of CCF over 23 years, emphasizing its low incidence of 0.37 per 100,000 patient-years. The median age at diagnosis was 51. All patients with neuro-ophthalmic evaluation exhibited chemosis and CN VI palsy, with other common findings including proptosis, third nerve palsy, and audible bruits. Notably, only half of the patients reported pain, potentially contributing to delayed diagnosis.

The key clinical takeaway is that CN VI palsy with a red eye should not be mistaken for a microvascular palsy. Careful examination of conjunctival vessels is crucial—dilated, corkscrew vessels extending to the limbus suggest elevated venous pressure and a likely fistula rather than thyroid eye disease.

Regarding imaging, noninvasive modalities like CT or MRI can suggest CCF by detecting a dilated superior ophthalmic vein. However, CTA and MRA have limitations, especially in low-flow fistulas, due to challenges in visualizing contrast drainage. A conventional catheter angiogram remains the gold standard for definitive diagnosis.

Ophthalmologists should maintain a high index of suspicion for CCF in patients with CN VI palsy and chemosis, as early detection and appropriate imaging are crucial for timely intervention.

Reference
  1. Cohen DA, Sanchez Moreno FR, Bhatti MT, Lanzino G, Chen JJ. Evaluating the incidence and neuro-ophthalmic manifestations of carotid-cavernous fistulas. J Neuroophthalmol. 2024;44(2):232-235. doi:10.1097/WNO.0000000000001973

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
© 2025 MJH Life Sciences

All rights reserved.